These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 19215012)
1. Cholesterol goals: moving from numbers to treatment. Vogel RA; Miller M Clin Cardiol; 2009 Feb; 32(2):106-8. PubMed ID: 19215012 [No Abstract] [Full Text] [Related]
2. A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1329-30. PubMed ID: 15297284 [No Abstract] [Full Text] [Related]
4. Updated guidelines support even lower cholesterol levels for at-risk patients. Levenson D Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342 [No Abstract] [Full Text] [Related]
5. Attaining United States and European guideline LDL-C levels with simvastatin in patients with coronary heart disease (the GOALLS study). Mikhailidis DP; Wierzbicki AS Curr Med Res Opin; 2000; 16(3):205-7. PubMed ID: 11191011 [No Abstract] [Full Text] [Related]
6. When the patient asks. How do I treat my high cholesterol? Hewett ML JAAPA; 2011 May; 24(5):63. PubMed ID: 21574536 [No Abstract] [Full Text] [Related]
7. Introduction: missing the target with lipid-lowering therapy. Hunninghake DB; McKenney JM Am J Manag Care; 2000 Nov; 6(19 Suppl):S992-6. PubMed ID: 11187370 [No Abstract] [Full Text] [Related]
8. The heart of the matter. National guidelines urge more aggressive cholesterol treatment. Leake NB Adv Nurse Pract; 2002 Jan; 10(1):42-7; quiz 48-9. PubMed ID: 12420511 [No Abstract] [Full Text] [Related]
9. [New results in the management of hypercholesterolemia]. Sármán B Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of hypercholesterolemia with enzyme inhibitors]. Valdés EF Medicina (B Aires); 1988; 48(4):425-8. PubMed ID: 3076202 [No Abstract] [Full Text] [Related]
12. National cholesterol education program (NCEP) guidelines too complex. Feeman WE Prev Cardiol; 2005; 8(3):188. PubMed ID: 16108130 [No Abstract] [Full Text] [Related]
13. Cholesterol-lowering drugs bring benefits to high-risk populations even when LDL is normal. Braun LT; Davidson MH J Cardiovasc Nurs; 2003; 18(1):44-9; quiz 75-6. PubMed ID: 12537089 [TBL] [Abstract][Full Text] [Related]
14. What are the priorities for managing cholesterol effectively? Brown WV Am J Cardiol; 2001 Aug; 88(4A):21F-4F. PubMed ID: 11520483 [TBL] [Abstract][Full Text] [Related]
16. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare? Gotto AM; Kuller LH Circulation; 2002 Jan; 105(2):136-9. PubMed ID: 11790688 [No Abstract] [Full Text] [Related]
17. [The "healthy" patient with hypercholesterolemia]. Klose G Med Klin (Munich); 2005 Feb; 100(2):99-106; quiz 107-8. PubMed ID: 15711905 [No Abstract] [Full Text] [Related]
18. LDL cholesterol: should guidelines include targets? Banerjee S; Kahali D; Banerjee A; Brilakis ES Expert Rev Cardiovasc Ther; 2014 Mar; 12(3):285-90. PubMed ID: 24502625 [TBL] [Abstract][Full Text] [Related]
19. [Cholesterol: how and when to treat it?]. Masana Marín L Med Clin (Barc); 1985 Oct; 85(10):423-5. PubMed ID: 4079497 [No Abstract] [Full Text] [Related]
20. Importance of dietary management and practical patient counseling--US perspective. Schaefer EJ Atheroscler Suppl; 2002 Oct; 3(3):17-22. PubMed ID: 12429169 [No Abstract] [Full Text] [Related] [Next] [New Search]